 Jian, Jiangxi, China, March 31, 2021 GLOBE NEWSWIRE -- Universe Pharmaceuticals INC the Company Nasdaq: UPC, a pharmaceutical producer and distributor in China, today announced the underwriter of its previously announced initial public offering of ordinary shares the Offering has exercised in full its option to purchase an additional 750,000 ordinary shares at the public offering price of 5.00 per share to cover overallotments, resulting in additional gross proceeds of 3.75 million. After giving effect to the full exercise of the over-allotment option, the total number of shares sold by the Company in the Offering increased to 5.75 million shares and gross proceeds increased to 28.75 million. The exercise of the over-allotment option has closed on March 31, 2021. 